Kymera Therapeutics KYMR Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Kymera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The official record: Kymera Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kymera Therapeutics's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kymera Therapeutics's short-term investments?
- Kymera Therapeutics (KYMR) reported short-term investments of $506.84M in Q1 2026.
- How has Kymera Therapeutics's short-term investments changed year-over-year?
- Kymera Therapeutics's short-term investments increased by 35.8% year-over-year, from $373.18M to $506.84M.
- What is the long-term trend for Kymera Therapeutics's short-term investments?
- Over 5 years (2020 to 2025), Kymera Therapeutics's short-term investments has grown at a 13.1% compound annual growth rate (CAGR), from $265.2M to $491.27M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.